UK markets closed
NIKKEI 225
37,552.16 +113.55 (+0.30%) HANG SENG
16,828.93 +317.24 (+1.92%) CRUDE OIL
83.24 +1.34 (+1.64%) GOLD FUTURES
2,341.10 -5.30 (-0.23%) DOW
38,491.54 +251.56 (+0.66%) Bitcoin GBP
53,627.38 +71.24 (+0.13%)
Jazz Pharmaceuticals plc (JAZZ)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:12PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.78B |
| Enterprise value | 10.95B |
| Trailing P/E | 17.83 |
| Forward P/E | 5.84 |
| PEG ratio (5-yr expected) | 0.82 |
| Price/sales (ttm) | 2.04 |
| Price/book (mrq) | 1.81 |
| Enterprise value/revenue | 2.86 |
| Enterprise value/EBITDA | 8.93 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.61 |
| 52-week change 3 | -22.91% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 146.70 |
| 52-week low 3 | 106.61 |
| 50-day moving average 3 | 119.52 |
| 200-day moving average 3 | 125.83 |
Share statistics
| Avg vol (3-month) 3 | 617.89k |
| Avg vol (10-day) 3 | 604.81k |
| Shares outstanding 5 | 62.35M |
| Implied shares outstanding 6 | 62.35M |
| Float 8 | 60.45M |
| % held by insiders 1 | 2.81% |
| % held by institutions 1 | 98.31% |
| Shares short (28 Mar 2024) 4 | 3.26M |
| Short ratio (28 Mar 2024) 4 | 3.98 |
| Short % of float (28 Mar 2024) 4 | 6.04% |
| Short % of shares outstanding (28 Mar 2024) 4 | 5.23% |
| Shares short (prior month 29 Feb 2024) 4 | 2.39M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 10.82% |
| Operating margin (ttm) | 23.18% |
Management effectiveness
| Return on assets (ttm) | 4.56% |
| Return on equity (ttm) | 12.16% |
Income statement
| Revenue (ttm) | 3.83B |
| Revenue per share (ttm) | 60.58 |
| Quarterly revenue growth (yoy) | 4.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.45B |
| Net income avi to common (ttm) | 414.83M |
| Diluted EPS (ttm) | 6.10 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.63B |
| Total cash per share (mrq) | 26.15 |
| Total debt (mrq) | 5.8B |
| Total debt/equity (mrq) | 155.21% |
| Current ratio (mrq) | 2.24 |
| Book value per share (mrq) | 60.03 |
Cash flow statement
| Operating cash flow (ttm) | 1.09B |
| Levered free cash flow (ttm) | 1.05B |
© 2024 Yahoo. All rights reserved.